2016 began with some tragic news in Europe, the death of one volunteer and severe adverse reactions in five others in a clinical trial being conducted in France. The Phase I study was being conducted by local company Biotrial on behalf of Portugal’s Bial-Portela & CA SA, and involved an investigational drug BIA-10-2474 being developed for CNS indications.
The last drug trial disaster in Europe was back in 2006 in the UK, and led to a tightening of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?